| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | C Svanborg | |
| D Karpman | |||
| H Fischer | |||
| M Yadav | |||
| A C Lundstedt | |||
| B Ragnarsdóttir | |||
| B Wullt | |||
| G Godaly | |||
| J Grönberg-Hernandez | |||
| M Gustafsson | |||
| M L Svensson | |||
| N Lutay | |||
| S Rämisch | |||
| P2860 | cites work | Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 |
| Virulence factors in Escherichia coli urinary tract infection | Q28468751 | ||
| Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling | Q28646137 | ||
| Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli | Q33494685 | ||
| Co-operative induction of pro-inflammatory signaling by Toll-like receptors | Q40783925 | ||
| Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice | Q40846592 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 12-20 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections | |
| P478 | volume | 38 Suppl 2 |
| Q82815425 | Asymptomatic bacteriuria: when the treatment is worse than the disease |
| Q54364557 | Bactofection with toll-like receptor 4 in a murine model of urinary tract infection. |
| Q36211391 | Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran |
| Q35689537 | Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes |
| Q34995541 | Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli |
| Q36410981 | Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae |
| Q27311900 | Diverging mechanisms of activation of chemokine receptors revealed by novel chemokine agonists |
| Q36262315 | Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli |
| Q98726083 | Epidemiology, definition and treatment of complicated urinary tract infections |
| Q43646743 | Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli |
| Q38142595 | From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa |
| Q34091450 | Genetic control of the variable innate immune response to asymptomatic bacteriuria |
| Q33762495 | Genetic risk for recurrent urinary tract infections in humans: a systematic review |
| Q37900471 | Genetics of innate immunity and UTI susceptibility. |
| Q36163174 | Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection |
| Q33701690 | Host imprints on bacterial genomes--rapid, divergent evolution in individual patients |
| Q37774543 | Host-pathogen interactions in urinary tract infection |
| Q30381843 | In silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infections |
| Q49879998 | Is vaginal reflux associated with urinary tract infection in female children under the age of 36 months? |
| Q34321369 | Modulating the innate immune response by combinatorial engineering of endotoxin |
| Q36161576 | Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets |
| Q35439695 | Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition |
| Q36181046 | New paradigms of urinary tract infections: Implications for patient management. |
| Q39238277 | Nitric oxide activates IL-6 production and expression in human renal epithelial cells |
| Q35005508 | Opportunistic bacterial infections in breeding colonies of the NSG mouse strain |
| Q33707731 | Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. |
| Q37983470 | Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections |
| Q37238866 | The innate immune response during urinary tract infection and pyelonephritis. |
| Q33652449 | The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection |
| Q40776374 | Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis. |
| Q51891134 | Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. |
| Q33519502 | Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli |
| Q48041390 | Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. |
| Q33613902 | Waging war against uropathogenic Escherichia coli: winning back the urinary tract |
Search more.